Mitkowska-Woźniak Hanna, Brazert Jacek, Wender-Ozegowska Ewa, Meissner Wioletta, Persona-Sliwińska Aleksandra, Pietryga Marek, Biczysko Romuald
Kliniki Połoznictwa i Chorób Kobiecych Katedry Ginekologii i Połoznictwa AM im. Karola Marcinkowskiego w Poznaniu.
Ginekol Pol. 2003 Nov;74(11):1444-9.
The purpose of the study was to assess the clinical value of sonographically measured abdominal subcutaneous tissue thickness (SCTAd) in prediction of large for gestational age in pregnancy complicated by diabetes mellitus.
We prospectively evaluated 256 pregnant women with gestational and pregestational diabetes mellitus longitudinally from 24th week of gestation until delivery. In all cases sonography was performed, and abdominal subcutaneous tissue thickness was assessed. After delivery the entire examined group was divided into two groups. The first group comprised mothers who delivered newborns with birth weight above 90th percentiles, and the second group comprised mothers who delivered newborns with birth weight between 10th and 90th percentiles.
Based on statistical analyses SCTAd was bigger in Group I than Group II (p. < 0.01) at the beginning of the 31st week of gestation. Based on ROC (receiver operating characteristic) curves we estimated that 5 mm thickness of abdominal subcutaneous tissues differentiate AGA (appropriate for gestational age) and LGA groups with 71% sensitivity and 72% specificity.
1/Use of the SCTAd permitted diagnosis of asymmetric fetal overgrowth complicated by diabetes mellitus since 31st week of gestation 2/5 mm of abdominal subcutaneous tissue thickness allowed differentiate AGA and LGA with 71% sensitivity and 72% specificity in term pregnancies complicated by diabetes mellitus.
本研究旨在评估超声测量的腹部皮下组织厚度(SCTAd)在预测妊娠合并糖尿病时大于胎龄儿方面的临床价值。
我们对256例妊娠合并糖尿病和孕前糖尿病的孕妇从妊娠第24周直至分娩进行了纵向前瞻性评估。所有病例均进行了超声检查,并评估了腹部皮下组织厚度。分娩后,将整个检查组分为两组。第一组包括分娩出生体重高于第90百分位数新生儿的母亲,第二组包括分娩出生体重在第10至第90百分位数之间新生儿的母亲。
基于统计分析,在妊娠第31周开始时,第一组的SCTAd大于第二组(p<0.01)。基于ROC(受试者工作特征)曲线,我们估计腹部皮下组织厚度5mm可区分适于胎龄儿(AGA)和大于胎龄儿(LGA)组,灵敏度为71%,特异度为72%。
1/使用SCTAd可自妊娠第31周起诊断妊娠合并糖尿病所致的不对称胎儿过度生长;2/腹部皮下组织厚度5mm可在妊娠合并糖尿病的足月妊娠中以71%的灵敏度和72%的特异度区分AGA和LGA。